54 results match your criteria: ""Madre Teresa di Calcutta" Hospital[Affiliation]"

Objectives: To first explore in Italy appropriateness of indication, adherence to guideline recommendations and mode of selection for coronary revascularisation.

Design: Retrospective, pilot study.

Setting: 22 percutaneous coronary intervention (PCI)-performing hospitals (20 patients per site), 13 (59%) with on-site cardiac surgery.

View Article and Find Full Text PDF

The authors reported a case of a 27-year-old man with a nontender left neck mass that had grown quite rapidly within few weeks. FNAB and CT were not consistent to establish the definite diagnosis. After excisional biopsy, the histopathological examination and the immunohistochemical study of the specimen revealed a cervical metastasis of seminoma.

View Article and Find Full Text PDF

Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases.

Am J Clin Oncol

August 2015

*Department of Radiation Oncology †Medical Physics Unit ‡Department of Palliative Therapies, Fondazione di Ricerca e Cura "Giovanni Paolo II," Università Cattolica del S. Cuore ∥Department of Oncology Regional, A. Cardarelli Hospital, Campobasso ¶Madre Teresa di Calcutta Hospice, Larino #Department of Neurological Sciences, Istituto Neurologico Mediterraneo Neuromed, Istituto di Ricovero e Cura a Carattere Scientifico, Pozzilli **Department of Radiation Oncology, "San Francesco" Hospital, Nuoro ‡‡Department of Radiotherapy, Università Cattolica del S. Cuore, Roma, Italy §Department of Radiation Oncology, The Lacks Cancer Center Saint Mary's Health Care, Grand Rapids, MI ††Department of Radiotherapy, Black Lion Hospital, Addis Ababa, Ethiopia.

Objectives: To assess the effectiveness of a SHort-course Accelerated RadiatiON therapy (SHARON) in the treatment of patients with multiple brain metastases.

Materials And Methods: A phase II clinical trial was designed. Eligibility criteria included patients with at least 3 brain metastases or metastatic disease in >3 organ systems, and Eastern Cooperative Oncology Group performance status of ≤3.

View Article and Find Full Text PDF

Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center.

Clin J Pain

November 2013

*Radiation Oncology Unit, Department of Oncology ¶Palliative Therapy Unit, Department of Oncology **Surgery Unit, Department of Oncology §Department of Anesthesia, Intensive Care and Pain Medicine ∥Medical Direction; Fondazione di Ricerca e Cura "Giovanni Paolo II", Università Cattolica del S. Cuore, Campobasso #Hospice Madre Teresa di Calcutta, Larino ††Department of Radiation Oncology, Università Cattolica del S. Cuore, Roma, Italy †Department of Radiation Oncology, The Lacks Cancer Center Saint Mary's Health Care, Grand Rapids, MI ‡Department of Radiation Oncology, Black Lion Hospital, Addis-Ababa, Ethiopia.

Objectives: The incidence of noncancer pain (NCP) in cancer patients is unknown. An analysis of incidence, severity, impact on quality of life (QoL), and appropriateness of NCP treatment in a cohort of cancer patients referred to a radiotherapy center is reported.

Materials And Methods: Pain was scored from 0 (absence) to 3 (severe) and the adequacy of analgesic therapy was evaluated according to International Guidelines.

View Article and Find Full Text PDF